Literature DB >> 1126892

Atropine modification of the pulmonary effects of chemical mediators in the guinea pig.

J M Drazen, K F Austen.   

Abstract

The actions of histamine, slow-reacting substance of anaphylaxis (SRS-A), Bradykinin, and prostaglandin F2alpha on pulmonary mechanics in the unanesthetized guinea pig were separated into direct and secondary cholinergic airway effects on the basis of alteration of their actions by atropine. The effects of SRS-A (500 and 3,000 units/kg) on compliance were not significantly altered by atropine, while the effects of bradykinin (3.0 and 30 mug/kg) on compliance were decreased only at 3.0 mug/kg by atropine. The effects of both of these agents on resistance were decreased by atropine, suggesting that SRS-A and bradykinin act directly on the peripheral airways and by secondary cholinergic mechanisms on both central and peripheral airways. The effects of histamine (3.0 mug/kg) on both compliance and resistance were abolished by atropine, suggesting an action mainly via cholinergic pathways; while at a higher dose, 9.0 mug/kg, there was both a direct and a cholinergic action. The effects observed 20 sec after the administration of prostaglandin F2alpha (PGF2alpha) were not altered by atropine suggesting a direct action on airways, while both the compliance and resistance changes observed 3-8 min after PGF2alpha were abolished by atropine suggesting that the latter effects were mediated solely by cholinergic mechanisms

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1126892     DOI: 10.1152/jappl.1975.38.5.834

Source DB:  PubMed          Journal:  J Appl Physiol        ISSN: 0021-8987            Impact factor:   3.531


  16 in total

1.  Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma.

Authors:  M K Albazzaz; K R Patel
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

2.  Response of human isolated bronchial and lung parenchymal strips to SRS-A and other mediators of asthmatic bronchospasm.

Authors:  A M Ghelani; M C Holroyde; P Sheard
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

3.  The effects of pentobarbitone and urethane on pulmonary airway resistance in guinea-pigs and their interactions with drugs.

Authors:  C Advenier; J R Boissier; S Ho; B Mallard; F Ruff
Journal:  Br J Pharmacol       Date:  1978-12       Impact factor: 8.739

4.  Atropine-enhanced, antigen challenge-induced airway hyperreactivity in guinea pigs is mediated by eosinophils and nerve growth factor.

Authors:  Norah G Verbout; David B Jacoby; Gerald J Gleich; Allison D Fryer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-15       Impact factor: 5.464

5.  Comparative responses of tracheal spirals and parenchymal strips to histamine and carbachol in vitro.

Authors:  J M Drazen; M W Schneider
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

6.  Inhaled antihistamines--bronchodilatation and effects on histamine- and methacholine-induced bronchoconstriction.

Authors:  S G Nogrady; C Bevan
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

7.  Involvement of capsaicin-sensitive afferent neurones in a vagal-dependent interaction between leukotriene D4 and histamine on bronchomotor tone.

Authors:  A G Stewart; D C Thompson; M R Fennessy
Journal:  Agents Actions       Date:  1984-12

Review 8.  Mast cells in allergic diseases and mastocytosis.

Authors:  D L Marquardt; S I Wasserman
Journal:  West J Med       Date:  1982-09

9.  Pharmacological modulation of inhaled sodium metabisulphite-induced airway microvascular leakage and bronchoconstriction in the guinea-pig.

Authors:  T Sakamoto; W Elwood; P J Barnes; K F Chung
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

10.  Effects of calcium channel and H1-receptor blockers on the responses of slowly adapting pulmonary stretch receptors to histamine in vagotomized rabbits.

Authors:  S Matsumoto; M Yamasaki; T Kanno; T Nagayama; T Shimizu
Journal:  Lung       Date:  1993       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.